Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Borsch Med is a prominent Singapore-based healthcare company that specializes in the research, development, and distribution of premium health supplements and traditional Chinese medicine (TCM). The company is well-regarded for its flagship products, including high-potency Lingzhi (Reishi mushroom) cracked spores and specialized glucosamine formulations for joint health. Borsch Med bridges the gap between traditional herbal remedies and modern nutritional science, ensuring product efficacy through rigorous quality standards. Its products are distributed extensively through major retail pharmacies, hospitals, and e-commerce platforms across Singapore and the broader Southeast Asian region. The company maintains a strong focus on consumer wellness, offering solutions for immunity, bone health, and organ function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Borsch Med.